These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8384776)

  • 21. Acute immune thrombocytopenic purpura: a comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin.
    Albayrak D; Işlek I; Kalaycí AG; Gürses N
    J Pediatr; 1994 Dec; 125(6 Pt 1):1004-7. PubMed ID: 7996346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-D immunoglobulin in the treatment of idiopathic thrombocytopenic purpura.
    Krishnamurti L; Charan VD; Desai N; Pati H; Choudhry VP
    Indian J Pediatr; 1994; 61(2):179-82. PubMed ID: 7927616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpura.
    Scaradavou A; Bussel JB
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):52-7. PubMed ID: 9523749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of intravenous immunoglobulin (2 g/kg totally) and single doses of anti-D immunoglobulin at 50 μg/kg, 75 μg/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience.
    Alioglu B; Ercan S; Tapci AE; Zengin T; Yazarli E; Dallar Y
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):505-9. PubMed ID: 23470649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of chronic immune thrombocytopenic purpura in children and adults.
    Blanchette V; Freedman J; Garvey B
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between IV immune globulin (IVIG) and anti-D globulin for treatment of immune thrombocytopenia: a randomized open-label study.
    Eghbali A; Azadmanesh P; Bagheri B; Taherahmadi H; Sadeghi Sedeh B
    Fundam Clin Pharmacol; 2016 Aug; 30(4):385-9. PubMed ID: 26991138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
    Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M
    Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of chronic autoimmune thrombocytopenic purpura with monoclonal anti-D.
    Godeau B; Oksenhendler E; Brossard Y; Bartholeyns J; Leaute JB; Duedari N; Schaeffer A; Bierling P
    Transfusion; 1996 Apr; 36(4):328-30. PubMed ID: 8623133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoglobulin anti-D for treatment of chronic ITP in children.
    Iacobini M; Duse M; Antonetti L; Smacchia MP; Schiavetti A
    Pediatr Blood Cancer; 2010 Dec; 55(7):1435. PubMed ID: 20981698
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of immune thrombocytopenic purpura in children : current concepts.
    Shad AT; Gonzalez CE; Sandler SG
    Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte subsets in patients with idiopathic thrombocytopenic purpura during high-dose gamma globulin therapy.
    Pogliani EM; Della Volpe A; Casaroli I; Maffe PF; Corneo G
    Allergol Immunopathol (Madr); 1991; 19(3):113-6. PubMed ID: 1799168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms.
    Cooper N; Heddle NM; Haas M; Reid ME; Lesser ML; Fleit HB; Woloski BM; Bussel JB
    Br J Haematol; 2004 Feb; 124(4):511-8. PubMed ID: 14984503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy and safety of a novel intravenous immunoglobulin preparation in adult chronic ITP.
    Colovic M; Dimitrijevic M; Sonnenburg C; Suvajdzic N; Donfrid M; Bogdanovic A
    Hematol J; 2003; 4(5):358-62. PubMed ID: 14502262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful anti-D immunoglobulin therapy in refractory chronic idiopathic thrombocytopenic purpura showing reduction in thrombocytes even after splenectomy.
    Shibuya A; Danya N; Shinozawa T
    Acta Paediatr Jpn; 1994 Jun; 36(3):297-300. PubMed ID: 8091983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T
    J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?
    Cooper N; Woloski BM; Fodero EM; Novoa M; Leber M; Beer JH; Bussel JB
    Blood; 2002 Mar; 99(6):1922-7. PubMed ID: 11877261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials.
    Qin YH; Zhou TB; Su LN; Lei FY; Zhao YJ; Huang WF
    Blood Coagul Fibrinolysis; 2010 Dec; 21(8):713-21. PubMed ID: 20962624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura.
    Fujisawa K; Iyori H; Ohkawa H; Konishi S; Bessho F; Shirahata A; Miyazaki S; Akatsuka J;
    Int J Hematol; 2000 Oct; 72(3):376-83. PubMed ID: 11185998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN; Kozuch P; Varma M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.